Speaker illustration

Associate Professor Mamoun Alhamadsheh

University of the Pacific, Stockton (United States of America)

AG10, an orally available, novel transthyretin (TTR) stabilizer: integrated preclinical evaluation predicts a highly effective treatment for TTR amyloid cardiomyopathy

Event: ESC CONGRESS 2017

Topic: Cardiomyopathies

Session: Cardiac amyloidosis

Thumbnail

This platform is supported by

logo Novo Nordisk